Prescient Therapeutics Limited (AU:PTX) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Prescient Therapeutics Limited has announced the cessation of 3 million options due to unmet conditions as of September 30, 2024. The options, initially set to expire on December 8, 2025, were discontinued because the required conditions were not satisfied. This update may interest investors tracking the company’s capital structure and future prospects.
For further insights into AU:PTX stock, check out TipRanks’ Stock Analysis page.